Nabumetone is a nonsteroidal anti-inflammatory drug, which has only rarely been associated with photosensitivity. We report a case of bullous lesions arising over photoexposed areas in a patient treated with nabumetone.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0190-9622(99)70507-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A review on toxic epidermal necrolysis-like superficial wound lesions: Issue and challenge on 10 clinical entities.
Int Wound J
December 2024
Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran.
Toxic epidermal necrolysis (TEN) is a severe skin reaction caused by extensive epidermal and mucosal necrosis. This clinical phenomenon is known as an acute syndrome of apoptotic pan-epidermolysis (ASAP). The ASAP phenomenon is observed in conditions that mimic TEN, highlighting the challenge in distinguishing these conditions.
View Article and Find Full Text PDFDrug-associated porphyria: a pharmacovigilance study.
Orphanet J Rare Dis
August 2024
Department of Pharmacy, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Article Synopsis
- * Researchers analyzed ADRs related to porphyria from January 2004 to March 2022 and narrowed down 406 drugs, ultimately identifying 52 drugs associated with adverse effects using various statistical algorithms.
- * The findings provide essential insights into the safety of drugs for porphyria carriers, helping healthcare providers make informed decisions and avoid prescribing harmful medications.
A rare case of meloxicam-induced pseudoporphyria.
Dermatol Online J
April 2024
Complete Dermatology, Conroe, Texas, USA.
Article Synopsis
- Drug-induced pseudoporphyria is often caused by NSAIDs like naproxen and ibuprofen, but this case highlights meloxicam as a potential cause.
- A 55-year-old woman with multiple health issues developed skin blisters on her feet, later diagnosed as pseudoporphyria linked to her meloxicam use.
- The patient's symptoms improved after stopping meloxicam, suggesting that awareness of this medication's risk can aid dermatologists in diagnosis and treatment.
Drug-Induced Pseudoporphyria: A Case Report.
Cureus
April 2024
Dermatology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Article Synopsis
- - Pseudoporphyria is a rare skin condition that resembles porphyria cutanea tarda (PCT), and distinguishing between the two is crucial for accurate diagnosis.
- - It’s linked to chronic kidney failure, certain medications, and tanning bed use, and can cause skin issues like fragility, blisters, and scarring, especially in sun-exposed areas.
- - A case report highlights a 20-year-old male diagnosed with pseudoporphyria after ruling out true porphyria, who was treated with hydroxychloroquine sulfate and advised to take strict sun protection measures.
Olaparib-induced pseudoporphyria in a patient with ovarian cancer.
JAAD Case Rep
September 2023
Department of Dermatology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!